Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Sjoerd Johannes Finnema
Introduction
Sjoerd Johannes Finnema is a notable inventor based in Stockholm, Sweden. With a background in pharmacology and a keen interest in neurology, he has made significant strides in the field of medical inventions. His work primarily focuses on enhancing patient outcomes, especially in the context of anesthesia.
Latest Patents
Sjoerd holds a patent for the invention titled "Use of alpha 7 nicotinic acetylcholine receptor agonists." This innovation relates to the application of specific alpha 7 nicotinic acetylcholine receptor agonists to facilitate emergence from general anesthesia. The implications of this patent are profound, as it seeks to improve the recovery process for patients under general anesthesia.
Career Highlights
Currently, Sjoerd is associated with Novartis AG, a global healthcare company recognized for its commitment to innovative medicines. His tenure at Novartis AG has allowed him to engage in cutting-edge research and contribute to various projects aimed at enhancing medical practices and patient safety.
Collaborations
Throughout his career, Sjoerd has collaborated with distinguished professionals in his field, including Markus Fendt and Dominik Feuerbach. These collaborations have enriched his research endeavors, allowing for a multifaceted approach to medical innovations and strengthening the impact of his work within the industry.
Conclusion
In summary, Sjoerd Johannes Finnema's contributions to the field of medical science exemplify the spirit of innovation. His patented invention addressing the use of alpha 7 nicotinic acetylcholine receptor agonists showcases his commitment to improving patient care and anesthesia practices. As he continues his work at Novartis AG, the potential for further advancements in medical technology remains promising.